MarketPeel
Insider Trading Intelligence
RH

Robert D. Hardie

ABOS
10% OWNER · ACUMEN PHARMACEUTICALS, INC. · CIK 0001804350
FILING MIX · LIFETIME55%/45%
BUYS
6
SELLS
5
TOTAL VALUE
$17.00M
COMPANIES
1
ACTIVE SINCE
Jul 2021
HOLDINGS NOW
0
AVG SELL PX
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Robert D. Hardie, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%-6.24%+0.62%-6.85%-6.85%
14d2+0.00%-8.37%-0.43%-7.93%-7.93%
30d2+0.00%-25.79%+2.04%-27.83%-27.83%
60d2+0.00%-22.82%+4.65%-27.48%-27.48%
90d2+0.00%-25.00%-0.67%-24.33%-24.33%
180d2+0.00%-66.68%+11.09%-77.77%-77.77%
1y2+0.00%-72.77%-10.21%-62.56%-62.56%
2y2+0.00%-75.00%+4.69%-79.69%-79.69%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABOS · 0 shares · as of Jul 6, 2021
0987,7891,975,5782,963,3673,951,156SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
FLOW · 6 buys / 5 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
ABOS
ACUMEN PHARMACEUTICALS, INC.
PURCHASE
750,000$16.00$12.00M3,951,156Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
PURCHASE
2,076,3263,201,156Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
SALE
2,076,3260Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
PURCHASE
1,124,8301,124,830Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
SALE
1,124,8300Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
PURCHASE
657,985657,985Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
PURCHASE
312,500$16.00$5.00M3,352,693Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
PURCHASE
2,950,4843,040,193Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
SALE
1,315,9690Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
SALE
1,634,5150Jul 6, 2021Jul 8, 2021
ABOS
ACUMEN PHARMACEUTICALS, INC.
SALE
657,9850Jul 6, 2021Jul 8, 2021
Other insiders · ABOS
Loading peer insiders…
About this filer
CIK 0001804350
ROLE
10% Owner
PRIMARY
ABOS
COMPANIES
1
ACTIVE SINCE
Jul 2021
MARKETPEEL · /INSIDER/0001804350DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback